Literature DB >> 7793356

Protective immunity induced by 67 K outer membrane protein of phase I Coxiella burnetii in mice and guinea pigs.

Y X Zhang1, N Zhi, S R Yu, Q J Li, G Q Yu, X Zhang.   

Abstract

A 67 K outer membrane protein (OMP) isolated from phase I Coxiella burnetii QiYi strain was purified with monoclonal antibodies (MoAb) coupled to CNBr-Sepharose 4B. Chemical analyses of the 67 K protein showed that it contained seventeen kinds of amino acids and no LPS. The immunogenicity and protectivity of the 67 K protein against C. burnetii was evaluated in mice and guinea pigs by in vitro lymphocyte proliferation assay, delayed-type skin test, antibody conversion rate, and immunization and challenge tests. Intraperitoneal injection of the 67 K protein resulted in antibody production against phase I and II whole cell antigens. The anti-67 K antibody conversion rate was found to be 100% in mice and guinea pigs as well. Lymphocytes were responses in vitro to specific antigen. In addition, delayed-type hypersensitivity appeared two weeks after immunization with the 67 K protein. Moreover, 100% of mice and guinea pigs inoculated with the 67 K protein were protected against a challenge with 10(3) ID50 virulent C. burnetii. In conclusion, these results demonstrate that the 67 K OMP elicits in vivo and in vitro both B cell-mediated and T cell-mediated immunity in mice and guinea pigs. Thus the 67 K protein is a candidate for an effective subunit vaccine against Q fever.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7793356

Source DB:  PubMed          Journal:  Acta Virol        ISSN: 0001-723X            Impact factor:   1.162


  9 in total

1.  Genome-wide profiling of humoral immune response to Coxiella burnetii infection by protein microarray.

Authors:  Adam Vigil; Rocio Ortega; Rie Nakajima-Sasaki; Jozelyn Pablo; Douglas M Molina; Chien-Chung Chao; Hua-Wei Chen; Wei-Mei Ching; Philip L Felgner
Journal:  Proteomics       Date:  2010-06       Impact factor: 3.984

2.  Immunization against the agent of human granulocytic ehrlichiosis in a murine model.

Authors:  W Sun; J W IJdo; S R Telford; E Hodzic; Y Zhang; S W Barthold; E Fikrig
Journal:  J Clin Invest       Date:  1997-12-15       Impact factor: 14.808

Review 3.  Adaptive immunity to the obligate intracellular pathogen Coxiella burnetii.

Authors:  Jeffrey G Shannon; Robert A Heinzen
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

4.  Candidate antigens for Q fever serodiagnosis revealed by immunoscreening of a Coxiella burnetii protein microarray.

Authors:  Paul A Beare; Chen Chen; Timo Bouman; Jozelyn Pablo; Berkay Unal; Diane C Cockrell; Wendy C Brown; Kent D Barbian; Stephen F Porcella; James E Samuel; Philip L Felgner; Robert A Heinzen
Journal:  Clin Vaccine Immunol       Date:  2008-10-08

5.  Identification and cloning of immunodominant antigens of Coxiella burnetii.

Authors:  Guoquan Zhang; Katalin Kiss; Rekha Seshadri; Laura R Hendrix; James E Samuel
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

6.  Immunoreactive Coxiella burnetii Nine Mile proteins separated by 2D electrophoresis and identified by tandem mass spectrometry.

Authors:  James R Deringer; Chen Chen; James E Samuel; Wendy C Brown
Journal:  Microbiology (Reading)       Date:  2010-10-28       Impact factor: 2.777

7.  Proteomics paves the way for Q fever diagnostics.

Authors:  Malgorzata Kowalczewska; Zuzana Sekeyová; Didier Raoult
Journal:  Genome Med       Date:  2011-07-30       Impact factor: 11.117

8.  Q Fever: current state of knowledge and perspectives of research of a neglected zoonosis.

Authors:  Sarah Rebecca Porter; Guy Czaplicki; Jacques Mainil; Raphaël Guattéo; Claude Saegerman
Journal:  Int J Microbiol       Date:  2011-12-13

9.  Soluble antigens derived from Coxiella burnetii elicit protective immunity in three animal models without inducing hypersensitivity.

Authors:  Anthony E Gregory; Erin J van Schaik; Alycia P Fratzke; Kasi E Russell-Lodrigue; Christina M Farris; James E Samuel
Journal:  Cell Rep Med       Date:  2021-12-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.